Chromatin-mediated alternative splicing in reward pathophysiology
奖赏病理生理学中染色质介导的选择性剪接
基本信息
- 批准号:10188481
- 负责人:
- 金额:$ 48.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingBehaviorBrainBrain regionCell Culture SystemChromatinChronicDNADataData SetEngineeringEnzymesEpigenetic ProcessFunctional disorderGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionHistone H3HistonesLearningLysineMediatingMental DepressionMental disordersMethylationModificationMolecularMusNatureNeurobiologyNeuronsNuclearPathologyPharmaceutical PreparationsPost-Translational Protein ProcessingPrevalenceProtein IsoformsProteinsPublishingRNA SplicingRewardsRoleSelf AdministrationSpliced GenesStimulusStructureTestingVolitionWorkaddictionbrain reward regionschromatin modificationchromatin remodelingcocaine exposureepigenomegene functiongenome-wideinnovationinterdisciplinary approachlearned behaviormRNA Precursormotivated behaviornovel strategiesresponsetranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY
The epigenome refers to covalent modifications of nuclear histone proteins and their
associated DNA, which function to regulate gene expression. There is a wealth of data
implicating epigenetic remodeling in neurobiological function and behavior, especially in the
context of reward pathologies, such as addiction and depression. However, due to the
promiscuity of the factors involved, previous studies have failed to distinguish between the mere
presence and the functional relevance of a given chromatin modification at a specific gene.
This limits the elucidation of the precise molecular mechanisms by which neuroepigenetic
remodeling regulates transcription. To address this, we utilize a multidisciplinary approach that
involves (1) analysis of chromatin immunoprecipiation (ChIP)- and RNA-sequencing (seq)
datasets from brain reward regions following volitional reward behavior and (2) direct
manipulation of such modifications, using an innovative strategy of gene-targeted epigenetic
editing using engineered transcription factors (ETFs).
The current proposal tests the hypothesis that histone posttranslational modifications
(HPTMs), specifically histone H3 lysine 36 methylation (H3K36me3), directly functions in
reward-mediated pre-mRNA alternative splicing. The rationale for this hypothesis includes
recently published data that both alternative splicing and H3K36me3 enrichment are highly
regulated by cocaine exposure, and our preliminary finding that there is a significant correlation
between genome-wide H3K36me3 enrichment and the splicing complexity of expressed
alternative isoforms. While chromatin-mediated alternative splicing is well established in cell-
culture systems, it has not yet been described as a mechanism in brain, despite the prevalence
of both widespread chromatin remodeling and alternative splicing in neurons. This proposal
outlines a novel strategy to demonstrate neuronal H3K36me3-mediated alternative splicing, and
the functional significance of this transcriptional mechanism to motivated behavior. In particular,
we will analyze neuronal changes in mouse brain reward regions following drug or natural
reward self-administration. This work will establish a strategy through which we can examine
additional mechanisms of chromatin-mediated alternative splicing in various brain regions,
expanding beyond the initial hypotheses of the current proposal.
项目摘要
表观基因组是指核组蛋白蛋白及其衍生物的共价修饰。
相关的DNA,其功能是调节基因表达。有大量的数据
暗示神经生物学功能和行为的表观遗传重塑,特别是在
奖励病理学的背景,如成瘾和抑郁。但由于
混杂的因素,以前的研究未能区分单纯的
特定基因处给定染色质修饰的存在和功能相关性。
这限制了对神经表观遗传的精确分子机制的阐明,
重塑调节转录。为了解决这个问题,我们采用多学科方法,
涉及(1)染色质免疫沉淀(ChIP)和RNA测序(seq)分析
意志奖励行为后大脑奖励区域的数据集和(2)直接
操纵这种修改,使用基因靶向表观遗传的创新策略,
使用工程化转录因子(ETF)进行编辑。
目前的建议测试的假设,组蛋白翻译后修饰
HPTMs,特别是组蛋白H3赖氨酸36甲基化(H3K36me3),直接作用于
奖励介导的前mRNA选择性剪接。这一假设的基本原理包括
最近发表的数据表明,选择性剪接和H3K36me3富集都是高度相关的。
我们的初步发现,
全基因组H3K36me3富集与表达的H3K36me3的剪接复杂性之间的关系,
替代同种型。虽然染色质介导的选择性剪接在细胞中已经很好地建立,
文化系统,它还没有被描述为一种机制,在大脑中,尽管流行
神经元中广泛的染色质重塑和选择性剪接。这项建议
概述了一种新的策略,以证明神经元H3K36me3介导的选择性剪接,
这种转录机制对动机行为的功能意义。特别是,
我们将分析药物或天然药物给药后小鼠大脑奖励区域的神经元变化,
奖励自我管理。这项工作将建立一个战略,通过它我们可以检查
不同脑区中染色质介导的可变剪接的其它机制,
超出了目前提案的最初假设。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single sample sequencing (S3EQ) of epigenome and transcriptome in nucleus accumbens.
伏隔核表观基因组和转录组的单样本测序 (S3EQ)。
- DOI:10.1016/j.jneumeth.2018.07.006
- 发表时间:2018
- 期刊:
- 影响因子:3
- 作者:Xu,SJ;Heller,EA
- 通讯作者:Heller,EA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth A Heller其他文献
Alternative splicing in addiction
成瘾中的选择性剪接
- DOI:
10.1016/j.gde.2025.102340 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:3.600
- 作者:
Akanksha Bhatnagar;Elizabeth A Heller - 通讯作者:
Elizabeth A Heller
Elizabeth A Heller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth A Heller', 18)}}的其他基金
Epigenetic regulation of Cdk5 in cognition and emotion
Cdk5在认知和情绪中的表观遗传调控
- 批准号:
10585391 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10434147 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10297955 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10621891 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse
在药物滥用中使用工程 ZFP 进行体内基因特异性调控
- 批准号:
8518823 - 财政年份:2013
- 资助金额:
$ 48.3万 - 项目类别:
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse
在药物滥用中使用工程 ZFP 进行体内基因特异性调控
- 批准号:
8663073 - 财政年份:2013
- 资助金额:
$ 48.3万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 48.3万 - 项目类别:
Research Grants